← Back to Clinical Trials
Recruiting NCT06904768

NCT06904768 Effect of Shoulder Sling Use on Balance and Mobility in Subacute Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06904768
Status Recruiting
Phase
Sponsor Arnaoutis Stylianos
Condition Hemiplegia
Study Type INTERVENTIONAL
Enrollment 17 participants
Start Date 2025-03-13
Primary Completion 2025-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Shoulder SlingNo Sling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 17 participants in total. It began in 2025-03-13 with a primary completion date of 2025-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study examines whether wearing a shoulder sling can improve balance and mobility in people who are recovering from a stroke. Participants will perform simple movement and balance tests twice-once with the sling and once without. The goal is to find out if using the sling helps patients feel more stable and safe during walking and everyday activities.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset) * Hemiplegia affecting one upper limb * Brunnstrom stage \< 4 for the affected upper limb * Functional Ambulation Category (FAC) score \> 3 * Age between 40 and 80 years * Ability to follow simple instructions * Medically stable to participate in balance and mobility testing * Signed informed consent Exclusion Criteria: * Severe cognitive impairment (e.g. MMSE \< 23) * Visual or vestibular disorders affecting balance * Significant orthopedic or musculoskeletal conditions of the lower limbs * Uncontrolled cardiovascular or pulmonary disease * Use of assistive devices that prevent sling application * Severe aphasia interfering with understanding or communication * Skin lesions or injuries at the shoulder region preventing sling use

Contact & Investigator

Central Contact

Stylianos Arnaoutis

✉ mscphys23001@uniwa.gr

📞 +306981199528

Principal Investigator

Nikolaos Chrysagis

STUDY CHAIR

University of West Attica

Frequently Asked Questions

Who can join the NCT06904768 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hemiplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06904768 currently recruiting?

Yes, NCT06904768 is actively recruiting participants. Contact the research team at mscphys23001@uniwa.gr for enrollment information.

Where is the NCT06904768 trial being conducted?

This trial is being conducted at Koropí, Greece.

Who is sponsoring the NCT06904768 clinical trial?

NCT06904768 is sponsored by Arnaoutis Stylianos. The principal investigator is Nikolaos Chrysagis at University of West Attica. The trial plans to enroll 17 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology